PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2020

Cytokine activin C ameliorates chronic neuropathic pain in peripheral nerve injury rodents by modulating the TRPV1 channel.

Mixed / Other

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 33095918 ↗2020Reported benefit

Cytokine activin C ameliorates chronic neuropathic pain in peripheral nerve injury rodents by modulating the TRPV1 channel.

MixedOtherRats, Sprague-Dawley; wild-type and TRPV1 knockout miceMale (rats)Intrathecal; local pre-administrationLocal pre-administration in established neuropathic pain

Model: Sciatic nerve axotomy and spinal nerve ligation in rats; chronic constriction injury in mice

Intrathecal activin C dose-dependently inhibited neuropathic pain and local pre-administration reduced pain behaviour, DRG macrophage infiltration and spinal microgliosis, with the effect abolished in TRPV1 knockout mice.

Extraction: extract · Supplied extraction confidence: 0.6. Machine-extracted fields require source verification.